Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Shieldin complex subunit 2 pseudogene 3 (SHLD2P3)
- Target
- SHLD2P3
- Molecular classification
- Other (Pseudogene)
01
Overview
Shieldin complex subunit 2 pseudogene 3 (SHLD2P3) is a non-protein-coding genomic sequence related by homology to the shieldin complex subunit 2 (SHLD2), which is an essential component of the DNA double-strand break repair machinery. Unlike SHLD2, SHLD2P3 does not produce a functional protein and is classified as a pseudogene. There is no evidence that SHLD2P3 acts as a therapeutic target, serves as a biomarker, or interacts with drugs. Its functional or disease relevance has not been documented, and it is not actionable for molecular targeting or therapy. SHLD2P3 is a pseudogene and is not a molecular or therapeutic target. For structured drug or disease information, refer to the protein-coding gene SHLD2 (Shieldin complex subunit 2).
02
Mechanism of action
None. No drugs or interventions reported to act via SHLD2P3
03
Biological functions
None directly. Pseudogenes can sometimes regulate gene expression or act as microRNA decoys, but this is not established for SHLD2P3
04
Disease associations
None specifically reported for SHLD2P3. The protein-coding SHLD2 is involved in DNA repair and is implicated in cancer predisposition, but this does not translate to the pseudogene
Beyond the preview
Go deeper on Shieldin complex subunit 2 pseudogene 3 (SHLD2P3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shieldin complex subunit 2 pseudogene 3 (SHLD2P3).